Nektar Therapeutics (NKTR)
NASDAQ: NKTRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 40.26 0.00%
NKTR stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.37B
- EPS (TTM)
- -$17.58
- Dividend yield
- None
- 52-week range
- 33.40 – 109.00
- Day range
- 38.45 – 40.35
- Volume / Avg
- 1.43M / 1.05M
- Beta
- —
- Shares outstanding
- 34.14M
- Next earnings
- Nov 5, 2026
52-week range
NKTR stock today
Shares of Nektar Therapeutics (NKTR) finished higher on Oct 7 at $40.26, a gain of 0.88% or $0.35 per share, versus the S&P 500's 0.22% decline. Shares are 63.1% below their 52-week high of $109.00 and 20.5% above the 52-week low of $33.40, near the bottom of the past year's range. Nektar Therapeutics has posted a net loss over the last twelve months (EPS of -$17.58), so its P/E ratio is not meaningful.
Nektar Therapeutics's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Nektar Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-2.20
Nektar Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ANABAnaptysBio Inc. | 45.65 | -4.68% | $1.36B | vs NKTR |
| KLRAKailera Therapeutics Inc. | 10.53 | -2.77% | $1.37B | vs NKTR |
| OMEROmeros Corporation | 18.75 | +1.30% | $1.36B | vs NKTR |
| AAPGAscentage Pharma Group International American Depository Shares | 14.90 | -7.27% | $1.39B | vs NKTR |
| TYRATyra Biosciences Inc. | 20.39 | +0.74% | $1.40B | vs NKTR |
| KARDKardigan Inc. | 13.83 | +2.52% | $1.29B | vs NKTR |
| KRSAKorsana Biosciences Inc. | 31.50 | -0.84% | $1.43B | vs NKTR |
| GHRSGH Research PLC | 21.06 | -2.14% | $1.45B | vs NKTR |
Indexes, lists and sector
Largest Health Care stocks
Nektar Therapeutics stock FAQ
What is Nektar Therapeutics's stock price today?
NKTR last traded at $40.26 as of Oct 7, 4:00 PM EDT, up 0.88% on the day. Prices are delayed at least 15 minutes.
When is Nektar Therapeutics's next earnings date?
Nektar Therapeutics is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-2.20.
What is the NKTR 52-week high?
The 52-week high for NKTR is $109.00 and the 52-week low is $33.40. The stock is currently 63.1% below its high.